Articles
October 20, 2025
Alnylam’s Commitment to Health Literacy for All
As a patient-centric organization, Alnylam is fully committed to promoting the principles of health literacy as an integral part of our innovation and culture.
Read More ›
September 30, 2025
How Alnylam’s Manufacturing Investments Bring RNAi Therapeutics to More Patients, Faster
Translating our pioneering work in RNAi not only requires innovation in the lab - it requires innovation in how we make our medicines.
Read More ›
September 9, 2025
Five in A Row! Alnylam Named a 2025 Best Workplace for Innovators by Fast Company
We're proud to be named a Best Workplace for Innovators by Fast Company for the 5th year in a row.
Read More ›
August 26, 2025
RNAi Therapeutics: 5 Things You Should Know about this Innovative Class of Medicines
What is RNAi and what do RNAi therapeutics do? Here are 5 things you should know!
Read More ›
August 11, 2025
Everest and Everything In Between: A Journey Back to Nepal
One Alnylam employee's personal and spiritual journey home to Nepal and Everest to raise money for cancer research.
Read More ›
July 13, 2025
Supporting Newcomer Entrepreneurs - Forward·Inc’s Challengers Pitch Competition
Alnylam recently sponsored Forward·Inc’s Challengers Pitch Competition, as part of our ongoing Alnylam Challengers social impact initiative.
Read More ›
May 20, 2025
Alnylam Publishes 2024 Corporate Responsibility Report
We've published our 2024 Corporate Responsibility Report detailing our efforts in our pillars: Patients, Science, Employees, Communities, Planet, and Governance
Read More ›
May 1, 2025
Challenge Accepted: How Culture Powers Innovation at Alnylam
Alnylam's Chief Human Resources Officer discusses how the company's culture powers innovation and our mission to transform lives through RNAi therapeutics.
Read More ›
March 25, 2025
2024 Year in Review & Look Ahead: CEO Yvonne Greenstreet Highlights a Pivotal Year for Aln ...
Alnylam CEO Yvonne Greenstreet reflects on the company's accomplishments in 2024 and highlights of the 2024 annual report.
Read More ›
February 21, 2025
A New Therapeutic Approach Seeks to Silence Devastating Neurological Diseases
Exploring the potential of RNAi therapeutics to tackle brain diseases with few or no treatments
Read More ›
FOLLOW US
